
|Articles|May 1, 2003
- Volume 0 0
Ranking the Costs of Illnesses
Advertisement
According to a report from the US Agency for Healthcare Research and Quality released in late March 2003, hypertension is the sixth most expensive medical condition, affecting 27 million people and costing $18 billion a year. Heart disease is the most expensive medical condition. In 1997, the year of the study, heart disease affected more than 17 million people at a cost of $58 billion. Cancer came in second, at $46 billion. Hypertension also accounted for the most out-of-pocket expenses?patients pay about 30% of the costs of the disease.
Articles in this issue
over 23 years ago
Compounding terbutaline solutionover 23 years ago
Contraceptive Sponge Makes Comebackover 23 years ago
Avlimil Is a Woman's Answer to Viagraover 23 years ago
Stormy Weather Provokes Asthmaover 23 years ago
Allergies Affect the Bottom Lineover 23 years ago
Treat the GERD and the Asthma Resolvesover 23 years ago
Think Before You Light Upover 23 years ago
Statins and High Blood Pressureover 23 years ago
Age a Nonissue for Lowering Cholesterolover 23 years ago
Can Cholesterol Drugs Help MS?Advertisement
Related to this article

How should a factor XIa inhibitor be incorporated into secondary stroke prevention?

OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.

Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.

The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.

Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.

Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
Glucose Monitoring: Timing Makes Every Reading Count
5


